Market Place
Sourcing Support
Lannett Successfully Emerges From Chapter 11 in Stronger Financial Position
16 Jun 2023 //
BUSINESSWIRE
Lannett`s Generic Solifenacin Succinate Receives Approval in the U.S.
06 Jun 2023 //
FDA
Lannett To Report Fiscal 2023 Second-Quarter Financial Results
25 Jan 2023 //
PR NEWSWIRE
Enforcement Report - Week of January 25, 2023
25 Jan 2023 //
FDA
Lannett Announces Patent Licenses To Be Used For Its Insulin Glargine
07 Nov 2022 //
PRNEWSWIRE
Lannett Expands Liquid Drug Manufacturing Capabilities
31 Oct 2022 //
CONTRACTPHARMA
Lannett Receives Fda Approval To Manufacture Numbrino® At Seymour Plant
21 Oct 2022 //
PRNEWSWIRE
Lannett Announces Sale Of Several Discontinued Generic Drugs
19 Oct 2022 //
PRNEWSWIRE
Lannett, Par join nationwide Adderall shortage
21 Sep 2022 //
FIERCEPHARMA
Adderall Shortages in US Spread to Two More Drug Suppliers
20 Sep 2022 //
BLOOMBERG
Lannett Announces Subject Dosing Complete For Pivotal Trial of Insulin Glargine
31 Aug 2022 //
PRNEWSWIRE
Lannett Reports Fiscal 2022 Fourth-Quarter, Full-Year Financial Results
24 Aug 2022 //
PRNEWSWIRE
Lannett To Report Fiscal 2022 Fourth-Quarter, Full-Year Financial Results
19 Aug 2022 //
PRNEWSWIRE
Lannett Company Generic Amphetamine Aspartate Receives Approval in US
08 Jul 2022 //
FDA
Lannett Reports Fiscal 2022 Third-Quarter Financial Results
04 May 2022 //
PRNEWSWIRE
Lannett To Report Fiscal 2022 Q3 Financial Results, Host Conference Call
27 Apr 2022 //
PRNEWSWIRE
LANNETT INITIATES PIVOTAL CLINICAL TRIAL FOR BIOSIMILAR INSULIN GLARGINE
29 Mar 2022 //
PRNEWSWIRE
Propel Bio Partners Commences Operations
18 Mar 2022 //
PRNEWSWIRE
Lannett to sell liquid drug manufacturing plant in Carmel for $10.5M
07 Mar 2022 //
PHARMABIZ
LANNETT Announces sale of liquid drug manufacturing plant for $10.5M
04 Mar 2022 //
PRNEWSWIRE
Lannett Announces Receipt Of Notice Of Non-Compliance From NYSE
04 Mar 2022 //
PRNEWSWIRE
Lannett to present at the 34th Annual Roth Conference on March 14
04 Mar 2022 //
PRNEWSWIRE
Enforcement Report - Week of February 23, 2022
23 Feb 2022 //
FDA
Lannett says FDA completes review of IND application for Insulin Glargine
21 Jan 2022 //
PRNEWSWIRE
Lannett introduces mycophenolate mofetil for oral suspension in US markets
01 Sep 2021 //
PHARMABIZ
Lannett Commences Marketing Mycophenolate Mofetil For Oral Suspension
30 Aug 2021 //
PRNEWSWIRE
Lannett Announces Fiscal 2021 Fourth-Quarter, Full-Year Financial Results
25 Aug 2021 //
PRNEWSWIRE
LANNETT expands respiratory pipeline, signs exclusive commercialization
29 Jul 2021 //
PRNEWSWIRE
Lannett Development Of Biosimilar Insulin Glargine Product Continues To Advance
09 Mar 2021 //
PRNEWSWIRE
Lannett Co Inc Generic Fosaprepitant Dimeglumine Receives Approval in US
06 Mar 2021 //
FDA
Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin
09 Feb 2021 //
PRNEWSWIRE
Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin
09 Feb 2021 //
PRNEWSWIRE
Lannett Pays Off, In Full, Remaining Term A Loans
30 Nov 2020 //
PRNEWSWIRE
Lannett Co Inc`s Generic Doxepin Hydrochloride Receives Approval in US
04 Nov 2020 //
FDA
Lannett Announces Notice Of Proposed Settlement And Dismissal With Prejudice
17 Aug 2020 //
PRNEWSWIRE
Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent® Diskus®
17 Aug 2020 //
PRNEWSWIRE
Lannett Announces Launch Of FDA Approved Levothyroxine Tablets
03 Aug 2020 //
PHARMABIZ
Lannett Co Inc`s Generic Doxepin Hydrochloride Receives Approval in US
31 Jul 2020 //
FDA
Lannett Launches Mexiletine HCl Capsules
23 Jul 2020 //
PRNEWSWIRE
Lannett & Cediprof Announce Distribution Agreement For An Approved Levothyroxine
16 Jul 2020 //
PRNEWSWIRE
Lannett Announces Restructuring, Cost Reduction Initiatives
13 Jul 2020 //
PRNEWSWIRE
Lannett Provides Update On Clinical Advancement Of Biosimilar Insulin Glargine
10 Jun 2020 //
PRNEWSWIRE
Lannett Co Inc`s Generic Clobazam Receives Approval in US
28 Apr 2020 //
FDA
FDA approves Lannett`s cocaine-based nasal spray
14 Jan 2020 //
PHARMA FILE
Enforcement Report - Week of December 25, 2019
26 Dec 2019 //
FDA
Lannett Receives FDA Approvals For Two Dosage Strengths Of Butalbital
21 Dec 2019 //
PR NEWSWIRE
Lannett Issues Voluntary Nationwide Recall Of Levetiracetam Oral Solution
20 Dec 2019 //
FDA
Lannett enters new insulin glargine deal with HEC
26 Nov 2019 //
SEEKING ALPHA
Lannett`s Generic Clobazam Receives Approval in US
31 Oct 2019 //
FDA
Lannett Enters Into Distribution Agreement For Posaconazole DRT
28 Aug 2019 //
PR NEWSWIRE
Lannett Enters Into Advisory Services Agreement With Strategic Alliance Partner
27 Aug 2019 //
PR NEWSWIRE
Lannett Launches Aspirin And Extended-Release Dipyridamole Capsules
19 Jun 2019 //
PR NEWSWIRE
Lannett closing Wyoming`s only drug manufacturing plant, laying off 80
17 Jun 2019 //
FIERCE PHARMA
Lannett Company launches generic Adderall
16 May 2019 //
PHARMABIZ
Lannett Receives FDA Approval For Aspirin & Ext-Release Dipyridamole Capsules
27 Mar 2019 //
PR NEWSWIRE
Lannett Purchases $24 Million Of Term Loans In Open Market Transactions
20 Mar 2019 //
PR NEWSWIRE
UK Biobank generates “largest open access resource of exome data”
11 Mar 2019 //
PMLIVE
Enforcement Report - Week of October 31, 2018
31 Oct 2018 //
FDA
